Enzymes Practice Questions

Q: Which of the following is a ribozyme?

Peptidyl Transferase. ***Peptidyl Transferase*** - This enzyme, a component of the **large ribosomal subunit**, is responsible for forming **peptide bonds** between amino acids during protein synthesis. - It is unique because its catalytic activity is performed by **ribosomal RNA (rRNA)**, making it a ribozyme rather than a protein enzyme. *Ribonuclease* - Ribonucleases are a class of enzymes that **catalyze the degradation of RNA** into smaller components. - They are typically **protein-based enzymes** and do not exhibit catalytic activity stemming from RNA itself. *Transpeptidase* - Transpeptidases are protein enzymes primarily involved in **bacterial cell wall synthesis**, catalyzing the cross-linking of peptidoglycan chains. - They are the target of **beta-lactam antibiotics** like penicillin, which inhibit their protein-based enzymatic activity. *Poly A polymerase* - This enzyme adds a **polyadenosine (Poly A) tail** to the 3' end of messenger RNA (mRNA) precursors. - Poly A polymerase is a **protein enzyme** and its activity is not derived from an RNA molecule.

Q: What is the mechanism of conversion of trypsinogen to trypsin?

Removal of part of protein. ***Removal of part of protein*** - The conversion of **trypsinogen to trypsin** is an example of **proteolytic activation**, where a specific part of the inactive precursor (zymogen) is cleaved off. - This cleavage occurs at the N-terminus of trypsinogen by **enteropeptidase (or enterokinase)** in the duodenum, exposing the active site and forming active trypsin. *Hydrolysis* - While the removal of a part of the protein involves **hydrolysis of peptide bonds**, this option is too general. - It does not specify the selective nature of the cleavage that leads to activation, nor the fact that it's a specific segment being removed. *Phosphorylation* - **Phosphorylation** is a common mechanism for regulating enzyme activity, but it involves the addition of a **phosphate group**, not the removal of a protein segment. - This process is typically mediated by kinases and does not activate trypsinogen. *Removal of Carboxyl group* - The activation of trypsinogen involves the removal of a small N-terminal peptide, not specifically the removal of a **carboxyl group** from the protein. - While enzymatic cleavage does involve breaking peptide bonds, stating "removal of carboxyl group" is imprecise and does not accurately describe the mechanism.

Q: Which of the following is an example of an exopeptidase?

Carboxypeptidases. ***Carboxypeptidases*** - **Carboxypeptidases** are enzymes that cleave the **C-terminal** (carboxyl end) amino acid from a polypeptide chain, making them a type of exopeptidase. - They are crucial in protein digestion, releasing individual amino acids from the end of protein chains. *Trypsin* - **Trypsin** is an **endopeptidase** that cleaves peptide bonds within protein chains, specifically at the carboxyl side of **lysine** or **arginine** residues. - It does not cleave amino acids from the ends of polypeptide chains. *Chymotrypsin* - **Chymotrypsin** is an **endopeptidase** that cleaves peptide bonds within a polypeptide chain, primarily at the carboxyl side of **tyrosine**, **tryptophan**, or **phenylalanine**. - Its action is internal to the protein sequence, not at the termini. *Elastase* - **Elastase** is also an **endopeptidase** that cleaves peptide bonds internally, specifically targeting small, uncharged amino acid residues like **alanine**, **glycine**, and **valine**. - Its primary role is to break down elastin, an elastic protein in connective tissues, but it does so by internal cleavage.

Q: Level of which of the following is not elevated in heart disease

5-nucleotidase. ***5-nucleotidase*** - While other enzymes like LDH, SGOT, and ALP can be elevated in various conditions including heart disease (especially in the context of tissue damage), 5-nucleotidase is **not typically elevated in heart disease**. - Its elevation is more commonly associated with **biliary obstruction** or certain liver pathologies. *LDH* - **Lactate dehydrogenase (LDH)** is a marker of **cellular damage** and can be elevated in myocardial infarction, though it is less specific than troponins. - LDH levels rise later than CK-MB and remain elevated longer, indicating persistent tissue injury. *SGOT* - **Serum glutamic oxaloacetic transaminase (SGOT)**, also known as **aspartate aminotransferase (AST)**, is elevated in acute **myocardial infarction** due to cardiac muscle damage. - While it's a marker for cardiac injury, it's not specific as it's also highly concentrated in the liver. *ALP* - **Alkaline phosphatase (ALP)** can be mildly elevated in heart failure due to **hepatic congestion** caused by reduced cardiac output. - While its primary diagnostic significance is in bone and liver disease, its elevation in advanced heart disease is usually a secondary consequence.

Q: Chymotrypsinogen is activated into chymotrypsin by:

Trypsin. ***Activation of Chymotrypsinogen by Trypsin*** - **Trypsin** is the primary enzyme responsible for the activation of **chymotrypsinogen** into its active form, **chymotrypsin**, by cleaving a specific peptide bond. - This activation is part of a cascade of proteolytic enzyme activations in the **pancreatic juice**, crucial for protein digestion in the small intestine. *Pepsin* - **Pepsin** is a protease active in the **stomach**, requiring an acidic environment for its activity, and is involved in the initial breakdown of proteins. - It does not play a role in the activation of pancreatic zymogens like chymotrypsinogen; its primary function is protein digestion in the gastric lumen. *Renin* - **Renin** is an enzyme primarily involved in the **renin-angiotensin-aldosterone system** (RAAS), which regulates blood pressure and fluid balance. - Its action involves cleaving **angiotensinogen** to form angiotensin I, and it has no role in the activation of digestive enzymes like chymotrypsinogen. *HCl* - **Hydrochloric acid (HCl)** is produced in the stomach and is essential for providing the acidic environment required for **pepsin's activity** and for denaturing proteins. - While HCl is crucial for digestion, it does not directly activate chymotrypsinogen; this activation is an enzymatic process carried out by another protease.

Q: Enzyme activity is expressed as?

Micromoles/min. ***Micromoles/min*** - Enzyme activity is typically measured by the rate at which an enzyme converts its **substrate into product**. - This rate is often expressed as the amount of product formed (e.g., **micromoles**) or substrate consumed per unit of time (e.g., **per minute**). *Millimoles/lit* - This unit expresses **concentration** (moles per liter) rather than a rate of reaction. - While enzyme reactions involve changes in substrate/product concentration, this unit alone does not describe the **activity or catalytic speed** of the enzyme. *Milli gm/lit* - This unit also expresses **concentration by mass** (milligrams per liter), not enzyme activity. - It does not account for the **time-dependent nature** of enzyme catalysis or the molar quantity of reactants/products. *Mg/dl* - This unit represents **concentration by mass** (milligrams per deciliter), commonly used for measuring substances like glucose or cholesterol in blood. - It is not appropriate for expressing the **catalytic rate or activity** of an enzyme.

Q: Citrate synthase is inhibited by -

ATP. ***ATP*** - **Citrate synthase**, a key enzyme in the Krebs cycle, is inhibited by **high levels of ATP**, indicating a high energy state in the cell. - This allosteric inhibition helps regulate the metabolic flux through the cycle, slowing it down when energy is abundant. *ADP* - **ADP** typically signifies a low energy state and would generally act as an **activator** rather than an inhibitor for metabolic pathways that produce ATP. - In this context, ADP would promote the activity of enzymes involved in energy generation, including those in the Krebs cycle. *Insulin* - **Insulin** is a hormone that promotes fuel storage and utilization, generally **activating** metabolic pathways rather than directly inhibiting enzymes like citrate synthase. - Its primary role is to regulate blood glucose levels and promote glucose uptake and utilization. *Glucagon* - **Glucagon** is a hormone that mobilizes fuel from storage and is typically associated with **catabolic processes**, often increasing metabolic activity in response to low blood glucose. - It does not directly inhibit citrate synthase; its main actions are on glucoregulation.

Q: How many isoenzymes does lactate dehydrogenase (LDH) have?

5, based on H and M polypeptide subunits. **5, based on H and M polypeptide subunits** - **Lactate dehydrogenase (LDH)** is a tetrameric enzyme, meaning it is composed of four polypeptide subunits. - These subunits can be either **H (heart)** type or **M (muscle)** type, leading to five distinct isoenzymes (**LDH-1, LDH-2, LDH-3, LDH-4, LDH-5**) based on their combinations (HHHH, HHHM, HHMM, HMMM, MMMM). *7, based on H and M polypeptide subunits* - While LDH is composed of two types of subunits, H and M, the possible combinations of these four subunits result in **five distinct isoenzymes**, not seven. - Seven isoenzymes are not a recognized number for LDH. *9, based on H and M polypeptide subunits* - The combination of two types of subunits in a tetrameric structure cannot yield nine unique isoenzymes. - This number is incorrect and not supported by the biochemistry of LDH. *3, based on H and M polypeptide subunits* - Three isoenzymes would imply either fewer than four subunits or a more restricted combination, which is not the case for LDH's tetrameric structure with H and M subunits. - This number is insufficient to account for all possible combinations.

Q: The predominant isozyme of LDH in lung is:

LD-3. ***LD-3*** - **LD-3** is the predominant **LDH isozyme** found in the **lungs**, spleen, pancreas, and lymph nodes. - Its elevation often suggests conditions affecting these organs, such as pulmonary embolism or pancreatitis. *LD-1* - **LD-1** is primarily associated with the **heart** and **red blood cells**. - Elevated levels are typically seen in conditions like myocardial infarction and hemolytic anemia. *LD-2* - **LD-2** is also found in the **heart** and **red blood cells**, though typically in lower concentrations than LD-1 in the heart. - It is often elevated after an MI, but typically LD-1 is elevated higher than LD-2 after an MI. *LD-5* - **LD-5** is predominantly found in the **liver** and **skeletal muscle**. - Its increase is indicative of liver damage or muscle injury, such as hepatitis or muscular dystrophy.

Q: Which of the following statements about the enzymes involved in the conversion of glucose to glucose-6-phosphate in glycolysis is true?

Glucokinase is induced by insulin.. ***Glucokinase is induced by insulin.*** - **Insulin** promotes glucose uptake and utilization in the liver and pancreatic beta cells, where glucokinase is primarily expressed. - Induction of **glucokinase** by insulin ensures that glucose is efficiently phosphorylated and trapped within hepatocytes when blood glucose levels are high. - This is a key mechanism for postprandial glucose homeostasis. *Incorrect: Hexokinase is specific for glucose.* - **Hexokinase** is NOT specific for glucose; it can phosphorylate various hexoses including **fructose**, **mannose**, and **galactose**. - Its broad substrate specificity distinguishes it from glucokinase, which has greater specificity for glucose. *Incorrect: Glucokinase is inhibited by glucose-6-phosphate.* - Unlike **hexokinase**, which is subject to product inhibition by glucose-6-phosphate, **glucokinase is NOT inhibited** by its product. - This lack of feedback inhibition allows glucokinase to continue phosphorylating glucose even when glucose-6-phosphate levels are elevated, which is appropriate for its role as a glucose sensor in liver and pancreatic beta cells. *Incorrect: Hexokinase has a high Km for glucose.* - **Hexokinase** has a **low Km** (~0.1 mM) for glucose, meaning it has high affinity and is saturated at normal blood glucose levels. - In contrast, **glucokinase** has a high Km (~10 mM), allowing it to respond proportionally to changes in blood glucose concentration.

Question 1

Which of the following is a ribozyme?

Accepted Answer

Peptidyl Transferase

Answer

Ribonuclease

Answer

Transpeptidase

Answer

Poly A polymerase

Question 2

What is the mechanism of conversion of trypsinogen to trypsin?

Accepted Answer

Removal of part of protein

Answer

Hydrolysis

Answer

Phosphorylation

Answer

Removal of Carboxyl group

Question 3

Which of the following is an example of an exopeptidase?

Accepted Answer

Carboxypeptidases

Answer

Trypsin

Answer

Chymotrypsin

Answer

Elastase

Question 4

Level of which of the following is not elevated in heart disease

Accepted Answer

5-nucleotidase

Answer

SGOT

Answer

ALP

Answer

LDH

Question 5

Chymotrypsinogen is activated into chymotrypsin by:

Accepted Answer

Trypsin

Answer

Pepsin

Answer

Renin

Answer

HCl

Question 6

Enzyme activity is expressed as?

Accepted Answer

Micromoles/min

Answer

Millimoles/lit

Answer

Milli gm/lit

Answer

Mg/dl

Question 7

Citrate synthase is inhibited by -

Accepted Answer

ATP

Answer

Insulin

Answer

Glucagon

Answer

ADP

Question 8

How many isoenzymes does lactate dehydrogenase (LDH) have?

Accepted Answer

5, based on H and M polypeptide subunits

Answer

7, based on H and M polypeptide subunits

Answer

9, based on H and M polypeptide subunits

Answer

3, based on H and M polypeptide subunits

Question 9

The predominant isozyme of LDH in lung is:

Accepted Answer

LD-3

Answer

LD-2

Answer

LD-5

Answer

LD-1

Question 10

Which of the following statements about the enzymes involved in the conversion of glucose to glucose-6-phosphate in glycolysis is true?

Accepted Answer

Glucokinase is induced by insulin.

Answer

Hexokinase is specific for glucose.

Answer

Glucokinase is inhibited by glucose-6-phosphate.

Answer

Hexokinase has a high Km for glucose.

Enzymes — MCQs

Enzymes — MCQs

On this page

Practice by Chapter

Want unlimited practice?